Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/23/2003CA2503681A1 Method for isolating and measuring proliferation of long-term label retaining cells and stem cells
10/23/2003CA2484681A1 Human papilloma virus detection with dna microarray
10/23/2003CA2483451A1 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
10/23/2003CA2482915A1 Endocrine cell lines and method of using the same
10/23/2003CA2482904A1 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003CA2482903A1 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003CA2482849A1 Method, system and kit for detecting an analyte in a sample
10/23/2003CA2482841A1 Method of measuring human cyp3a inducibility
10/23/2003CA2482824A1 Method for the identification of modulators of a secretase activity
10/23/2003CA2482716A1 Method of forming pancreatic .beta. cells from mesenchymal cells
10/23/2003CA2482692A1 Method of analyzing molecule and molecule analyzer
10/23/2003CA2482658A1 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl)
10/23/2003CA2482634A1 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
10/23/2003CA2482612A1 Use of substances for treatment of tumors
10/23/2003CA2482317A1 Haptoglobin fragments diagnostic of alzheimers disease
10/23/2003CA2482313A1 Heterocyclic compounds
10/23/2003CA2482293A1 Method of nondestructive examination of chromium-containing nickel-based alloy for grain boundary corrosion and examination apparatus
10/23/2003CA2482244A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
10/23/2003CA2482129A1 Methods for determining levels of human b-type natriuretic peptide precursors
10/23/2003CA2482126A1 Luminescent markers
10/23/2003CA2481905A1 Mutation detection and identification
10/23/2003CA2481895A1 Methods and reagents for assaying protein kinase activity
10/23/2003CA2481827A1 Polyvalent cation-sensing receptor in atlantic salmon
10/23/2003CA2481632A1 Method of detecting an analyte in a fluid
10/23/2003CA2481545A1 Immunoassay probe
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481508A1 G-protein coupled receptor ligands and methods
10/23/2003CA2481503A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003CA2481501A1 Monitoring blood substances using self-sampled tears
10/23/2003CA2481478A1 Stimulation of nerve cell regeneration
10/23/2003CA2481420A1 Method for cleaving and deglycosylating antibodies to promote ligand binding
10/23/2003CA2481387A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
10/23/2003CA2481378A1 A sample surface component for an instrument that measures viscosity and viscoelasticity
10/23/2003CA2481358A1 Method for making a molecularly smooth surface
10/23/2003CA2481355A1 Hydrophobic zone device
10/23/2003CA2481349A1 Peptides for detection of antibody to a. phagocytophilum
10/23/2003CA2481328A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003CA2481231A1 Colon tumor specific binding peptides
10/23/2003CA2481186A1 Attenuated gram negative bacteria
10/23/2003CA2481087A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003CA2481051A1 Multi-parameter assays including analysis discs and methods relating thereto
10/23/2003CA2481042A1 Mycoplasma polypeptides
10/23/2003CA2480990A1 Methods and devices for performing chemical reactions on a solid support
10/23/2003CA2480986A1 Process control based on microbiological activity
10/23/2003CA2480836A1 Method for characterising analytes
10/23/2003CA2480775A1 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003CA2480745A1 Methods for treating tweak-related conditions
10/23/2003CA2480665A1 Use of na,k-atpase a-and b-subunits in bladder cancer detection and drug screening
10/23/2003CA2480491A1 High-density lipoprotein assay device and method
10/23/2003CA2480202A1 System and method for data analysis, manipulation, and visualization
10/23/2003CA2479835A1 An ephrin-b receptor protein involved in carcinoma
10/23/2003CA2479818A1 System and method for integrated computer-aided molecular discovery
10/23/2003CA2478398A1 Methods for identifying compounds that modulate enzymatic activity
10/23/2003CA2478395A1 Methods for identifying allosteric sites
10/22/2003EP1355256A2 Computer method and devices for biomolecule analysis
10/22/2003EP1355159A1 Use of fragments of carbamyl phosphate synthetase I (CPS 1) for the diagnosis of inflammatory diseases and sepsis
10/22/2003EP1355158A1 Method for diagnosing inflammatory and infectious diseases by detecting the phosphoprotein LASP-1 as inflammation marker
10/22/2003EP1355157A1 FADD proteins, phosphorylated p38-MAPK and FasL as tumours markers
10/22/2003EP1355155A1 Combinational biosensor
10/22/2003EP1355154A2 Accelerator for agglutination reactions, reagent for biochemical assays, and biochemical assay method
10/22/2003EP1355153A1 Screening method for agents against cardiovascular diseases
10/22/2003EP1355152A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen
10/22/2003EP1355149A2 Assessing colorectal cancer
10/22/2003EP1355148A1 Method to assess the presence of defects, such as cracks or bevelled edges, on the surface of wooden boards
10/22/2003EP1355147A2 Probe for measuring the alcohol content in liquids
10/22/2003EP1355146A2 Use of the multipin platform as anchor device
10/22/2003EP1355145A1 A method for analysing metals in the fundamental state utilizing the statistical distribution of elements
10/22/2003EP1354962A1 Use of the slug gene or of the transcription or expression products thereof in the detection and/or treatment of cancerous cells
10/22/2003EP1354961A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
10/22/2003EP1354951A1 Method of examining ability to control nerve cell plasticity
10/22/2003EP1354949A1 Human fgf23 protein mutant lowering blood phosphorus level
10/22/2003EP1354946A1 Bhlh-pas proteins, genes thereof and utilization of the same
10/22/2003EP1354945A1 Method of identifying within a mammala dna encoding physiologically active polypeptide
10/22/2003EP1354943A2 Monoclonal antibodies, hybridomas, cell isolation method, isolated cells and immunological diagnostic method
10/22/2003EP1354892A1 Peptides capable of inducing attraction of the axonal growth and their use for treating neurodegenerative diseases
10/22/2003EP1354890A1 Novel polypeptide and dna thereof
10/22/2003EP1354889A1 Trasncription activation complex and utilization thereof
10/22/2003EP1354210A1 Method for cancer diagnostics
10/22/2003EP1354209A2 Method for identifying compounds to treat medical pathologies associated with molecular crystallization
10/22/2003EP1354208A2 Methods of diagnosis and treatment of osteoporosis
10/22/2003EP1354206A2 Standard diluent for multiplex assays
10/22/2003EP1354205A2 Methods and agents for detecting the probability of the future occurrence or progression of diseases that are associated with a disorder of the no metabolism
10/22/2003EP1354204A2 Hcv antigen/antibody combination assay
10/22/2003EP1354203A2 Biomarkers of transitional cell carcinoma of the bladder
10/22/2003EP1354202A1 Method for detecting pancreatic and gastro-intestinal illnesses
10/22/2003EP1354201A2 Peptide biosensors for anthrax protease
10/22/2003EP1354200A2 Method of screening for gpr40 ligands
10/22/2003EP1354199A2 Diagnosis and treatment of multiple sclerosis
10/22/2003EP1354198A2 Method for the analysis of soluble analytes
10/22/2003EP1354197A1 Surface chemical modification of optical elements
10/22/2003EP1354196A2 Diagnostics, drug screening and treatment for cancer
10/22/2003EP1354195A2 SYSTEM AND METHOD FOR i IN VITRO /i ANALYSIS OF THERAPEUTIC AGENTS
10/22/2003EP1354194A2 Device and method for analyzing fat of meat
10/22/2003EP1354191A2 Oxygen monitoring apparatus and methods of using the apparatus
10/22/2003EP1354189A2 Rapid test for biological substances using ftir
10/22/2003EP1354188A2 Apparatus for the detection and measurement of particulates in molten metal
10/22/2003EP1354186A2 Lateral flow testing device with on-board chemical reactant
10/22/2003EP1354184A2 A method of wear testing a tire
10/22/2003EP1354079A2 Methods of searching for solid forms and screening a sample according to its forms
10/22/2003EP1354062A2 Target activated nucleic acid biosensor and methods of using same